• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

WearLinq Acquires AMI Cardiac Monitoring, Raises $6.7M for FDA-Cleared 6-Lead ECG Device

by Fred Pennic 05/21/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– WearLinq, a leader in wearable health monitoring, announced a strategic acquisition of AMI Cardiac Monitoring, LLC, a seasoned player in ambulatory cardiac monitoring. 

– The acquisition, coupled with a recent $6.7M funding round, positions WearLinq to significantly expand access to their innovative eWave 6-lead ECG monitor and revolutionize the fight against atrial fibrillation (AFib), which recently received FDA 510(k) clearance. 

Tackling the Silent Threat of AFib

AFib, a heart rhythm irregularity, affects one in three people in their lifetime. It increases stroke risk fivefold and often leads to heart failure. Yet, current diagnostic methods miss a significant portion of cases, with over 30% of patients receiving false negatives and needing retesting within six months.

WearLinq’s eWave: A Powerful Tool for Early Detection

WearLinq’s eWave 6-lead ECG device seeks to address these shortcomings. This wearable technology offers cardiologists a detailed, multidimensional view of the heart, ensuring accurate P-wave detection and exceptional ECG clarity. Here’s what sets the eWave apart:

  • Patient Comfort: Designed for comfort and minimal intrusion, the eWave allows patients to maintain their daily routines while undergoing cardiac monitoring.
  • Long-Term Monitoring: The device works seamlessly with a smartphone for extended monitoring periods. A convenient, AirPods-like charging case ensures continuous operation.
  • Advanced Data Analysis: Integrated with a state-of-the-art cloud platform, the eWave provides near real-time data analysis and actionable insights for healthcare providers.
  • Skin-like Adhesive Patches: WearLinq’s patent-pending adhesive patches ensure secure and comfortable wear.

Joe Knight Appointed to Board of Directors

The acquisition of AMI Cardiac Monitoring expands WearLinq’s ability to offer their eWave technology across all 50 states and provide expansive clinical services. Additionally, WearLinq welcomes industry veteran Joe Knight, co-inventor of iRhythm’s ZioPatch, to their Board of Directors. Knight’s expertise will be invaluable as WearLinq continues to innovate and disrupt the cardiac monitoring landscape.

"We are excited to join forces with WearLinq, a company at the forefront of cardiac monitoring innovation. This partnership aligns perfectly with our mission to provide exceptional diagnostic services," said Dorothy Glodek, Founder of AMI Cardiac Monitoring, LLC. "By integrating WearLinq's advanced 6-lead ECG technology with our extensive clinical expertise, we can offer unparalleled cardiac care to patients nationwide. Together, we are set to revolutionize the field of ambulatory cardiac monitoring, ensuring more accurate diagnoses and improved patient outcomes."
  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Atrial Fibrillation, Cardiac Monitoring, FDA clearance 510k, Healthcare Mergers & Acquisitions, heart arrhythmia detection, heart disease

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

The AI Paradox in Healthcare: Notable CEO Shares Why Moving Too Slowly is a Greater Risk

Most-Read

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

KLAS Report: Epic's Native Ambient Speech Tool Reshapes Customer AI Strategies

KLAS Report: Epic’s Native Ambient Speech Tool Reshapes Customer AI Strategies

Epic Unveils MyChart Central and New APIs to Advance Interoperability at Open@Epic

Epic Outlines Roadmap for Next-Generation Data Sharing at Open@Epic

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

Oracle Confirms Layoffs in Kansas City

Oracle Confirms Layoffs in Kansas City

Philips Future Health Index 2025: AI and Digital Tech Can Help Solve Cardiac Care Crisis

Philips Future Health Index 2025: AI and Digital Tech Can Help Solve Cardiac Care Crisis

Optain Health Secures $26M to Advance AI-Powered Retinal Screening

Optain Health Secures $26M for AI-Powered Retinal Screening

Sutter Health and Epic Launch "Sutter Sync" to Optimize Remote Chronic Care

Sutter Health and Epic Launch “Sutter Sync” to Optimize Remote Chronic Care

Patient Square Capital Acquires Premier in $2.6B Deal

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |